Skip to main content
. 2024 May 6;22:eAO0138. doi: 10.31744/einstein_journal/2024AO0138

Table 2. Antifungal susceptibility profile of isolates of Candida spp. of patients with oral candidiasis who underwent liver transplantation.

Species Collection A (n=15)
Antifungal MIC Variation (μg/mL) MIC50 (μg/mL) MIC90 (μg/mL) Sensitive n (%) SDD n (%) Resistant n (%)
C. albicans (n=9) Fluconazole 0.125-8 0.25 4 8 (88.9) 1 (11.1) -
Amphotericin B 0.25-2 0.5 1 9 (100) - -
Micafungin 0.03-0.5 0.03 0.03 9 (100) - -
C. glabrata (n=3) Fluconazole 0.125-4 0.25   - 3 (100) -
Amphotericin B 0.25-1 1   3 (100) - -
Micafungin 0.03-0.5 0.03   3 (100) - -
C. dubliniensis (n=1) Fluconazole 0.5 0.5   1 (100) - -
Amphotericin B 0.5 0.5   1 (100) - -
Micafungin 0.03 0.03   1 (100) - -
C. tropicalis (n=2) Fluconazole 4-8 4   - 1 (50) 1 (50)
Amphotericin B 0.5-1 0.5   2 (100) - -
Micafungin 0.03-0.03 0.03   2 (100) - -
  Collection B (n=15)
C. albicans (n=9) Fluconazole 0.125-8 0.25 8 6 (66.7) 2 (22.2) 1 (711.1)
Amphotericin B 0.25-2 0.5 1 9 (100) - -
Micafungin 0.03-0.5 0.03 0.03 9 (100) - -
C. glabrata (n=3) Fluconazole 0.5-1 0.5   - 3 (100) -
Amphotericin B 0.25-1 1   3 (100) - -
Micafungin 0.03-0.5 0.03   3 (100) - -
C. dubliniensis (n=2) Fluconazole 0.125-2 0.5   2 (100) - -
Amphotericin B 0.5-1 0.5   2 (100) - -
Micafungin 0.03-0.03 0.03   2 (100) - -
C. tropicalis (n=1) Fluconazole 4 4   - 1 (100) -
Amphotericin B 0.06 0.06   1 (100) - -
Micafungin 0.03 0.03   1 (100) - -

MIC: minimum inhibitory concentration; C: Candida; SDD: dose-dependent sensitivity; MIC50: antifungal concentration able to inhibit 50% of all isolates tested; MIC90: antifungal concentration able to inhibit 90% of all isolates tested.